• control
  • Education about glucose control has been shown to have a major impact on the patient's overall health. (health.am)
  • CONCLUSIONS: A report will be published in 1998 after a median duration from randomization of 11 years (range, 6 to 20 years) with an 81% power at a 1% level of significance of detecting whether the obtained improvement in glucose control causes a 15% decrease or increase in the incidence of major complications and whether any specific therapy is advantageous or disadvantageous. (ox.ac.uk)
  • The continuous glucose monitoring results help patients control and alter food intake, exercise, and medications. (psmarketresearch.com)
  • Blood
  • The global self-monitoring blood glucose (SMBG) devices market accounted for $11,171.1 million in 2014, and it is expected to grow with a CAGR of 5.7% during 2015-2022. (psmarketresearch.com)
  • In addition, many tests can be performed using a single glucose meter with different blood glucose strips. (psmarketresearch.com)
  • Also, the increase in healthcare expenditure leads to increase spending on self-monitoring blood glucose devices, resulting in the growth of the market. (psmarketresearch.com)
  • The positive reimbursement of self-monitoring blood glucose devices in major countries including the U.S., the U.K., Germany, France, Italy, Spain, and Japan is the key growth driving factor for its market. (psmarketresearch.com)
  • The technological advancement in the global market of self-monitoring blood glucose is leading to increased acceptances of such devices. (psmarketresearch.com)
  • The restraints associated with the growth of the global market of self-monitoring blood glucose include the product recalls due to either the manufacturing defect or error in results. (psmarketresearch.com)
  • The key companies operating in the global self-monitoring blood glucose devices market include Abbott Laboratories Inc., Medtronic Inc., Hoffmann-La Roche Ltd., Bayer AG , B. Braun Melsungen AG, Nipro Diagnostics Inc., Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, and Bionime Corporation. (psmarketresearch.com)